Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00015886
What this trial is testing

Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences 25
Testing effectiveness (Phase 2)Study completedNCT00002669
What this trial is testing

Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 90
Early research (Phase 1)Study completedNCT00098423
What this trial is testing

Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+23 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00628810
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 86
Testing effectiveness (Phase 2)Study completedNCT00900627
What this trial is testing

Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)

Who this might be right for
NeoplasmsBreast NeoplasmsBreast Cancer
AstraZeneca 330
Testing effectiveness (Phase 2)Looking for participantsNCT07668154
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants

Who this might be right for
HNSCC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00673569
What this trial is testing

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Large-scale testing (Phase 3)Study completedNCT00556322
What this trial is testing

Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 424
Testing effectiveness (Phase 2)Study completedNCT00512681
What this trial is testing

A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
National Cancer Center, Korea 44
Testing effectiveness (Phase 2)Ended earlyNCT00427973
What this trial is testing

AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00873756
What this trial is testing

Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT01064622
What this trial is testing

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 118
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06892431
What this trial is testing

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Who this might be right for
Recurrent or Metastatic Nasopharyngeal CancerPatients Who Have Experienced Treatment Failure at Least Second-line Chemotherapy
Shanghai JMT-Bio Inc. 150
Early research (Phase 1)Ended earlyNCT02824575
What this trial is testing

Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast AdenocarcinomaHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast+2 more
Montefiore Medical Center 28
Early research (Phase 1)Looking for participantsNCT06063681
What this trial is testing

SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced / Metastatic Solid Tumor
Stingray Therapeutics 25
Testing effectiveness (Phase 2)Study completedNCT04205630
What this trial is testing

SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Byondis B.V. 64
Testing effectiveness (Phase 2)Study completedNCT01094405
What this trial is testing

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Who this might be right for
Nasopharyngeal CancerEpstein-Barr Virus Infections
Chinese University of Hong Kong 25
Testing effectiveness (Phase 2)Study completedNCT00005831
What this trial is testing

Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer

Who this might be right for
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+3 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT01494012
What this trial is testing

Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Recurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorMalignant Tumor of Peritoneum+2 more
Stanford University 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817901
What this trial is testing

Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Yonsei University 46
Next Page